Enfermedad cardiovascular asociada a las terapias supresoras de andrógenos utilizadas para el tratamiento del cáncer de próstata: una revisión de alcance

Autor: Santos, Trinnye Luizze, Lima, Caroline Silva de Araujo, Souza, Gregório Lauar e, Oliveira, Márcia Farsura de, Belinati, Karen Daher, Pinzon, Ana Paula Avila, Pavoni, Bianca de Campos, Drummond Júnior, Délio Guerra, Guedes, Idrys Henrique Leite, Foloni, Bianca Volpe

Publikováno v: Research, Society and Development; Vol. 11 No. 11; e162111133570
Research, Society and Development; Vol. 11 Núm. 11; e162111133570
Research, Society and Development; v. 11 n. 11; e162111133570
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI

Worldwide, prostate cancer (PCa) represents the second leading cause of death from cancer in the male population, and shares many of the risk factors that also predispose to the emergence of cardiovascular diseases (CVD's). The established treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::92ecd2f7c7e10c56453375651c34bae5
https://rsdjournal.org/index.php/rsd/article/view/33570